Covered recipient · General Payments record
VIVIANE B ACKAD
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2025
$404.90
- Reported across 10 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $404.90 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Insulet Corporation | $139.84 | 1 |
| Novo Nordisk AS | $139.47 | 2 |
| Amgen Inc. | $37.20 | 2 |
| Merck Sharp & Dohme Corporation | $32.54 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $22.77 | 1 |
| Acerta Pharma LLC | $18.15 | 1 |
| Gilead Sciences, Inc. | $14.93 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $404.90 | 10 |
Payment records · PY2025 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.20 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228525701 | CMS |
| Amgen Inc. | $19.00 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228525703 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.15 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207182326 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $22.77 | 08/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225436549 | CMS |
| Gilead Sciences, Inc. | $14.93 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234572456 | CMS |
| Insulet Corporation | $139.84 | 08/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207110790 | CMS |
| Merck Sharp & Dohme LLC | $14.62 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238316904 | CMS |
| Merck Sharp & Dohme LLC | $17.92 | 05/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238083431 | CMS |
| Novo Nordisk Inc | $119.55 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188985229 | CMS |
| Novo Nordisk Inc | $19.92 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188617377 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.